Association between single nucleotide polymorphisms of NOTCH signaling pathway-related genes and the prognosis of NSCLC

References

• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.2010721296855
   PubMed Web of Science ®Google Scholar
• Chen WQ, Sun KX, Li H, et al. Report of cancer Incidence and Mortality in China, 2014. Zhonghua Zhong Liu Za Zhi. 2018;40(1):5–13. doi:10.3760/cma.j.issn.0253-3766.2018.01.00229365411
   PubMedGoogle Scholar
• Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003-2005: a population-based study. Int J Cancer. 2015;136(8):1921–1930. doi:10.1002/ijc.2922725242378
   PubMed Web of Science ®Google Scholar
• Lyu J, Hao X, Hui Z, et al. Prognosis of R1-resection at the bronchial stump in patients with non-small cell lung cancer. Chin Med J (Engl). 2014;127(16):2918–2923.25131228
   PubMed Web of Science ®Google Scholar
• Xu CH, Sheng ZH, Hu HD, et al. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer. Tumour Biol. 2014;35(9):8673–8678. doi:10.1007/s13277-014-2039-124870591
   PubMedGoogle Scholar
• Fan H, Shao ZY, Xiao YY, et al. Incidence and survival of non-small cell lung cancer in Shanghai: a population-based cohort study. BMJ Open. 2015;5(12):e009419. doi:10.1136/bmjopen-2015-009419
   PubMed Web of Science ®Google Scholar
• Qian Z, Qingshan C, Chun J, et al. High expression of TNFSF13 in tumor cells and fibroblasts is associated with poor prognosis in non-small cell lung cancer. Am J Clin Pathol. 2014;141(2):226–233. doi:10.1309/AJCP4JP8BZOMHEAW24436270
   PubMed Web of Science ®Google Scholar
• Chen X, Chen D, Yang S, et al. Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients. Cancer Cell Int. 2015; 15(1):43. doi:10.1186/s12935-015-0191-325960692
   PubMedGoogle Scholar
• Lamba JK, Fridley BL, Ghosh TM, et al. Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small cell lung cancer. Pharmacogenomics. 2014;15(12):1565–1574. doi:10.2217/pgs.14.10725340731
   PubMed Web of Science ®Google Scholar
• Takebe N, Ivy SP. Controversies in cancer stem cells: targeting embryonic signaling pathways. Clin Cancer Res. 2010;16(12):3106–3112. doi:10.1158/1078-0432.CCR-09-293420530695
   PubMed Web of Science ®Google Scholar
• Yu Z, Pestell TG, Lisanti MP, et al. Cancer stem cells. Int J Biochem Cell Biol. 2012;44(12):2144–2151. doi:10.1016/j.biocel.2012.08.02222981632
   PubMed Web of Science ®Google Scholar
• Hittelman WN, Liao Y, Wang L, et al. Are cancer stem cells radioresistant? Future Oncol. 2010;6(10):1563–1576. doi:10.2217/fon.10.12121062156
   PubMed Web of Science ®Google Scholar
• Yuan X, Wu H, Han N, et al. Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application. J Hematol Oncol. 2014;7:87. doi:10.1186/s13045-014-0087-z25477004
   PubMed Web of Science ®Google Scholar
• Shao S, Zhao X, Zhang X, et al. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a slug-dependent manner. Mol Cancer. 2015;14:28. doi:10.1186/s12943-015-0295-325645291
   PubMed Web of Science ®Google Scholar
• Zhang Z, Bu X, Yang J, et al. NOTCH4 regulates colorectal cancer proliferation, invasiveness, and determines clinical outcome of patients. J Cell Physiol. 2018;233(10):6975–6985. doi:10.1002/jcp.26619
   PubMed Web of Science ®Google Scholar
• Huntzicker EG, Hotzel K, Choy L, et al. Differential effects of targeting Notch receptors in a mouse model of liver cancer. Hepatology. 2015;61(3):942–952. doi:10.1002/hep.2756625311838
   PubMed Web of Science ®Google Scholar
• Liu ZY, Wu T, Li Q, et al. Notch signaling components: diverging prognostic indicators in lung adenocarcinoma. Medicine (Baltimore). 2016;95(20):e3715. doi:10.1097/MD.000000000000371527196489
   PubMed Web of Science ®Google Scholar
• Xiong J, Zhang X, Chen X, et al. Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. Oncotarget. 2017;8(8):13157–13165. doi:10.18632/oncotarget.1448328061457
   PubMedGoogle Scholar
• Qp X, Rd X, Wm X, et al. Association between polymorphism in notch signaling pathway and lung cancer risk. Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52(3):243–252. doi:10.3760/cma.j.issn.0253-9624.2018.03.00629973002
   PubMedGoogle Scholar
• Alexander M, Wolfe R, Ball D, et al. Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer. Br J Cancer. 2017;117(5):744–751. doi:10.1038/bjc.2017.23228728168
   PubMed Web of Science ®Google Scholar
• Kim JS, Cho MS, Nam JH, et al. Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer. PLoS One. 2017;12(5):e0177015. doi:10.1371/journal.pone.017701528486527
   PubMed Web of Science ®Google Scholar
• Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989;342(6250):705–708. doi:10.1038/342705a02531845
   PubMed Web of Science ®Google Scholar
• Johnson L, Mercer K, Greenbaum D, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature. 2001;410(6832):1111–1116. doi:10.1038/3507412911323676
   PubMed Web of Science ®Google Scholar
• Li W, Zhou J, Chen Y, et al. Cigarette smoke enhances initiation and progression of lung cancer by mutating Notch1/2 and dysregulating downstream signaling molecules. Oncotarget. 2017;8(70):115128–115139. doi:10.18632/oncotarget.2292429383147
   PubMedGoogle Scholar
• Zong D, Ouyang R, Li J, et al. Notch signaling in lung diseases: focus on Notch1 and Notch3. Ther Adv Respir Dis. 2016;10(5):468–484. doi:10.1177/175346581665487327378579
   PubMed Web of Science ®Google Scholar
• Costa MJ, Wu X, Cuervo H, et al. Notch4 is required for tumor onset and perfusion. Vasc Cell. 2013;5(1):7. doi:10.1186/2045-824X-5-723601498
   PubMedGoogle Scholar
• Chen C, Wang X, Huang S, et al. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer. Oncotarget. 2017;8(20):32731–32740. doi:10.18632/oncotarget.1638728415574
   PubMedGoogle Scholar
• Xu J, Song F, Jin T, et al. Prognostic values of Notch receptors in breast cancer. Tumour Biol. 2016;37(2):1871–1877. doi:10.1007/s13277-015-3961-626323259
   PubMedGoogle Scholar
• Wang JW, Wei XL, Dou XW, et al. The association between Notch4 expression, and clinicopathological characteristics and clinical outcomes in patients with breast cancer. Oncol Lett. 2018;15(6):8749–8755. doi:10.3892/ol.2018.844229805613
   PubMed Web of Science ®Google Scholar
• Rizzo P, Miao H, D’souza G, et al. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res. 2008;68(13):5226–5235. doi:10.1158/0008-5472.CAN-07-574418593923
   PubMed Web of Science ®Google Scholar
• Metodieva SN, Nikolova N, Cherneva RV, et al. Expression analysis of angiogenesis-related genes in Bulgarian patients with early-stage non-small cell lung cancer. Tumori. 2011;97(1):86–94. doi:10.1177/03008916110970011621528670
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang R, Wang X, et al. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer. Medicine. 2018;97(52):e13817. doi:10.1097/MD.000000000001381730593175
   PubMed Web of Science ®Google Scholar
• Tradonsky A, Rubin T, Beck R, et al. A search for reliable molecular markers of prognosis in prostate cancer: a study of 240 cases. Am J Clin Pathol. 2012;137(6):918–930. doi:10.1309/AJCPF3QWIG8FWXIH22586051
   PubMed Web of Science ®Google Scholar